AbbVie is using innovative technologies like AI, wearables and automation to speed up drug discovery, clinical trials, and ...

Patient assistance programs (PAPs) emerged to help patients who lack health insurance or prescription drug coverage obtain ...

“We recognize that those with rare diseases often have complex needs that go unmet by traditional assistance,” said Green.

On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a ...

The global Cystic Fibrosis Market is valued at $10.4 billion in 2023 and is projected to reach $55.4 billion by 2032, ...

AbbVie said in a statement that the timing of patient access to Vyalev is "dependent on their individual insurance plan," adding that it expects Medicare coverage to start "in the second half of ...

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...

Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...

AbbVie has agreed a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will give it control of a preclinical-stage, oral drug for psoriasis. US-based Nimble was set up in ...

Connected care experience company Oneview Healthcare has launched its generative artificial intelligence AI (GenAI) assistant ...

**NM signifies a non meaningful value. A dash signifies the data is not available.